Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
WEISS, Tobias
GLIOMOON, NCT03779230: Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse	Completed	1/2	20	Europe	L19TNF, onfekafusp alpha	Philogen S.p.A.	Glioma of Brain	06/23	06/23
GLIOSTAR, NCT04573192: A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression	Recruiting	1/2	142	Europe	L19TNF, onfekafusp alfa, Lomustine	Philogen S.p.A.	Glioblastoma	03/25	12/25
GLIOSUN, NCT04443010: Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma	Recruiting	1/2	226	Europe	Onfekafusp alfa, L19TNF, Temozolomide, TMZ	Philogen S.p.A.	Glioblastoma	10/26	12/26